openPR Logo
Press release

Stent Graft Balloon Catheter Market Size is Estimated to Reach US$ 1.6 Billion by 2031

11-24-2023 12:06 PM CET | Health & Medicine

Press release from: Fact.MR

According to the most recent market research report from Fact.MR, the global stent graft balloon catheter market is expected to be worth over US$ 800 million in 2020, or roughly 3.5% of the total catheter market. By 2031, sales of stent graft balloon catheters are expected to reach US$ 1.6 Bn, growing at a CAGR of 7%. The market for compliant balloon stent catheters is expected to grow rapidly from 2021 to 2031, with a CAGR of 5%.

Sophisticated healthcare infrastructure, rising awareness about balloon angioplasty procedures, and growing demand for Expanded stent graft balloon catheters are further expected to influence the growth of the market over the coming years.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:https://www.factmr.com/connectus/sample?flag=S&rep_id=149?PJ

The market for stented graft balloon catheters is extensively covered in the report. The market for stented graft balloon catheters can grow successfully if certain crucial factors are taken into account, according to the report. These characteristics include things like market size, expansion, revenue, sales, demand, risks, dangers, opportunities, economic outlook, and history, among many other things.

๐—ง๐—ต๐—ฒ ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฝ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€, ๐˜„๐—ต๐—ถ๐—ฐ๐—ต ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ: -

Medtronic Plc
Cordis Corporation
B. Braun Melsungen AG
Cook Medical INC
Terumo Corporation
Boston Scientific Corporation
MicroPort Scientific Corporation
Jotech GmbH
Cardionovum GmbH
Hexacath
Abbott Laboratories
Meril Life Sciences Pvt. Ltd.

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

๐—ฃ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ ๐—ง๐˜†๐—ฝ๐—ฒ
Compliant Balloon Stent Catheters
Non-compliant Balloon Stent Catheters

๐—˜๐—ป๐—ฑ-๐˜‚๐˜€๐—ฒ๐—ฟ
Stent Graft Balloon Catheters for Hospitals
Stent Graft Balloon Catheters for Ambulatory Surgical Centers
Stent Graft Balloon Catheters for Cardiac Catheterization Laboratories

๐—œ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป
Stent Graft Balloon Catheters for Coronary Artery Disease
Stent Graft Balloon Catheters for Peripheral Vascular Disease
Stent Graft Balloon Catheters for Balloon Angioplasty
Stent Graft Balloon Catheters for Bypass Graft Surgery
Stent Graft Balloon Catheters for Atherosclerosis Patients

๐—ฅ๐—ฎ๐˜„ ๐— ๐—ฎ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฎ๐—น
Polyurethane Stent Graft Balloon Catheters
Nylon Stent Graft Balloon Catheters
Others

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

Expansions, capital investments, R&D activities, technological developments, new product releases, distribution agreements, product portfolios, collaborations, mergers & acquisitions, and strategic alliances are all used by top manufacturers of stent graft balloon catheters.

Top stent graft balloon catheter suppliers have implemented an expansion strategy to increase their production capabilities to meet the growing demand for diverse applications. Several product developments in stent graft balloon catheters are being approved by regulatory bodies for treating vascular diseases.

For example, the FDA recently approved an expandable balloon stent graft developed by W.L. Gore & Associates for the treatment of peripheral artery disease.

๐—ž๐—ฒ๐˜† ๐—ฃ๐—ผ๐—ถ๐—ป๐˜๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐˜๐—ฒ๐—ป๐˜ ๐—š๐—ฟ๐—ฎ๐—ณ๐˜ ๐—•๐—ฎ๐—น๐—น๐—ผ๐—ผ๐—ป ๐—–๐—ฎ๐˜๐—ต๐—ฒ๐˜๐—ฒ๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

Growing Prevalence of Vascular Diseases: The stent graft balloon catheter market has been influenced by the increasing incidence of vascular diseases, such as abdominal aortic aneurysms (AAA) and peripheral artery disease (PAD).

Minimally Invasive Procedures: Stent graft balloon catheters are used in endovascular or minimally invasive procedures, which offer several benefits over traditional open surgeries, including reduced hospital stays, faster recovery times, and lower risks of complications.

Aneurysm Repair: Stent graft balloon catheters are commonly employed for endovascular repair of aortic aneurysms, both in the abdominal (AAA) and thoracic (TAA) regions.

Peripheral Artery Disease (PAD): The devices are also used to treat narrowing or blockages in peripheral arteries, helping to improve blood flow in the legs and other peripheral regions.

Technological Advancements: Continuous innovation in the design and materials of stent graft balloon catheters aims to improve their efficacy, flexibility, and deliverability during procedures.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:https://www.factmr.com/connectus/sample?flag=RC&rep_id=149?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stent Graft Balloon Catheter Market Size is Estimated to Reach US$ 1.6 Billion by 2031 here

News-ID: 3302108 • Views: โ€ฆ

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโ€ฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โ€ฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโ€ฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโ€ฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โ€ฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโ€ฆ

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lungโ€ฆ
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on anโ€ฆ
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P โ€ฆ
The latestย Globalย Gel Stentย Marketย research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. Theย Gel Stentย market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market.ย There is wide acceptance of Gel Stent across the buyers' segments and this has been driving theโ€ฆ
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas โ€ฆ
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entireโ€ฆ
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp โ€ฆ
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some ofโ€ฆ
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patientsโ€ฆ